Reposal

Revision as of 14:25, 6 September 2012 by WikiBot (talk | contribs) (Robot: Automated text replacement (-{{reflist}} +{{reflist|2}}, -<references /> +{{reflist|2}}, -{{WikiDoc Cardiology Network Infobox}} +))
Jump to navigation Jump to search
Reposal
Clinical data
SynonymsReposal, 5-Ethyl-5-(bicyclo(3.2.1)octenyl)barbituric acid
ATC code
Identifiers
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC14H18N2O3
Molar mass262.304 g/mol

Reposal is a barbiturate derivative invented in the 1960s in Denmark. It has sedative, hypnotic and anticonvulsant properties, and was used primarily for the treatment of insomnia. [1] [2]



References

  1. Kessing SV, Tarding F, Thomsen AC. Reposal, A New Hypnotic. (Danish) Ugeskrift for Læger. 1963 Dec 6;125:1735-1741.
  2. Nielsen P, Tarding F. The metabolic fate of 5-(bicyclo-3,2,1,-oct-2-en-2-yl)-5-ethyl barbituric acid, (Reposal). Acta Pharmacologica et Toxicologica (Copenhagen). 1968;26(6):521-30.

Template:Chem-stub

Template:Barbiturates

de:Reposal